These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20853085)

  • 1. [Aspects of health economic evaluations as a contribution to the priority-setting debate in Germany].
    Brüggenjürgen B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Sep; 53(9):890-5. PubMed ID: 20853085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Decision support through economic evaluation from the perspective of science in Germany].
    Graf von der Schulenburg JM
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 May; 55(5):660-7. PubMed ID: 22526854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Priority setting in healthcare. What can Germany learn from other countries?].
    Busse R; Hoffmann C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Sep; 53(9):882-9. PubMed ID: 20853084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of health economic evaluations in Sweden.
    Heintz E; Arnberg K; Levin LÅ; Liliemark J; Davidson T
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):375-82. PubMed ID: 25444295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ethical basis of priority setting in healthcare].
    Marckmann G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Sep; 53(9):867-73. PubMed ID: 20853082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priority-setting, rationing and cost-effectiveness in the German health care system.
    Oduncu FS
    Med Health Care Philos; 2013 Aug; 16(3):327-39. PubMed ID: 22692518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Priorization in healthcare. An important duty, an unnecessary luxury, or playing with fire? A sociomedical point of view].
    Raspe H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Sep; 53(9):874-81. PubMed ID: 20853083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Decision-analytical modelling of costs per QALY in the context of the German Social Law].
    Rogowski WH; Landauer M; John J
    Gesundheitswesen; 2009 Nov; 71(11):739-50. PubMed ID: 19551622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prioritization is actually quite a self-evident evaluation process, however it may not supplant the important debate about rationalization (interview by Heiner Raspe and Sabine Stumpf)].
    Schlenker RU; Raspe H; Stumpf S
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(6):404-6. PubMed ID: 22857726
    [No Abstract]   [Full Text] [Related]  

  • 10. Decision making in Germany: is health economic evaluation as a supporting tool a sleeping beauty?
    Gerber-Grote A; Sandmann FG; Zhou M; Ten Thoren C; Schwalm A; Weigel C; Balg C; Mensch A; Mostardt S; Seidl A; Lhachimi SK
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):390-6. PubMed ID: 25444297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health economic evaluations in reimbursement decision making in the Netherlands: time to take it seriously?
    Franken M; Koopmanschap M; Steenhoek A
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):383-9. PubMed ID: 25444296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Priority to whom? Prioritizing in the public health system].
    Willich SN
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Sep; 53(9):865-6. PubMed ID: 20853081
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rationing health care by thresholds for clinical benefit and its acceptance by the German population].
    Schöne-Seifert B; Friedrich DR; Diederich A
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(6):426-34. PubMed ID: 22857730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Economic and ethical aspects of the development of treatment guidelines].
    Lauterbach KW
    Z Arztl Fortbild Qualitatssich; 1997 Jun; 91(3):277-82. PubMed ID: 9312433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Critical reflections on the prioritisation debate: are we setting the right priorities to address our prioritisation challenges?].
    Penner A
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(6):397-403. PubMed ID: 22857725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the contribution of health economic evaluations to decision-making in health care? Experiences from 7 selected countries.
    Gerber-Grote A; Windeler J
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):358-9, 355-7. PubMed ID: 25444292
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rationing in public health: what criteria, what priorities?].
    Wiedemann GJ; Thor-Wiedemann S
    Med Klin (Munich); 1999 Feb; 94(2):116-9. PubMed ID: 10194959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assessment of the value of health-care services--the first step].
    Porzsolt F
    Med Klin (Munich); 2008 May; 103(5):321-4. PubMed ID: 18484218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The acceptance of personal responsibility as a criterion in assigning health care benefits. An empirical study].
    Diederich A; Schreier M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Sep; 53(9):896-902. PubMed ID: 20853086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.